Metazym

Metazym is being trialed in Patients with late infantile Metachromatic Leukodystrophy^[1]. The drug produced by Shire costs in the vicinity of US$90,000 per month ^[2]. A company spokesman notes that the drug will not be on the market until at least 2012

Notes

1. ^ http://clinicaltrials.gov/ct2/show/NCT00681811
2. ^ http://www.smh.com.au/world/sick-childs-parents-dump-175m-outside-drugs-firm-20090716-dlts.html